Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oktopi is an Australia-based life sciences software company building an AI-informed knowledge and workflow platform for medicine development. Rather than developing its own therapeutic pipeline, the company provides cognitive infrastructure, expert-curated taxonomies, decision logic, peer review workflows, and capability-building tools intended to improve decision quality, transparency, and efficiency across the drug development lifecycle. Its product suite includes OktoWai, OktoPilot, OktoLearning, and The Consortium, which together support biopharma teams, governance bodies, and global health organizations. Oktopi appears particularly focused on democratizing access to high-quality development expertise for smaller developers and innovators in low- and middle-income countries. The company has received Gates Foundation support and has announced ecosystem and commercial partnerships including AusBiotech and AdAlta.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oktopi.